Article
Adverse effects of 5-aza-2'-deoxycytidine on spermatogenesis include reduced sperm function and selective inhibition of de novo DNA methylation.
The Journal of pharmacology and experimental therapeutics - 1 Sept 2007
Oakes Christopher C, Kelly Tamara L J, Robaire Bernard, Trasler Jacquetta M
Abstract excerpt
The anticancer agent, 5-aza-2'-deoxycytidine (5-azaCdR, decitabine), causes DNA hypomethylation and a robust, dose-dependent disruption of spermatogenesis. Previously, we have shown that altered testicular histology and reduced sperm production in 5-azaCdR-treated animals is associated with decreased global sperm DNA methylation and an increase in infertility and/or a decreased ability to support preimplantation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
